GE commits $25M to making surgery safer; Bolton gets CE mark for AAA stent;

@FierceMedDev: ICYMI: Study: 3-D tissue marker helps improve breast cancer monitoring, aids recovery. Article | Follow @FierceMedDev

@VarunSaxena2: Four key medical device recalls of 2015. Feature | Follow @VarunSaxena2

@EmilyWFierce: ICYMI: EU regulators crack down on Brazilian devicemaker for implant safety scare. Article | Follow @EmilyWFierce

> The GE Foundation is leading an effort to commit $25 million over three years to improve to improve global surgical capacity, infrastructure, and training. More

> NEA-backed startup Cartiva has started a clinical trial for its Synthetic Cartilage Implant (SCI) in the treatment of first carpometacarpal (CMC) joint osteoarthritis at the base of the thumb. More

> Bolton Medical has gotten a CE mark or its Treo Abdominal Stent-Graft System used to treat abdominal aortic aneurysms (AAAs). More

Biotech News

@FierceBiotech: ICYMI: Aduro adds checkpoint inhibitors to a 'breakthrough' mix in $32M buyout. Article | Follow @FierceBiotech

@JohnCFierce: Think the drug pricing issue is going away? Washington Post: The secret truth. Report | Follow @JohnCFierce

@DamianFierce: As a longtime appreciator of dumb corporate M&A codenames, "Project Potsticker" is a solid addition. Bloomberg story | Follow @DamianFierce

> Troubled GlaxoSmithKline to shutter R&D facility in France. Story

> Roche, Boehringer and Gilead line up for EU drug approvals. News

> AbbVie dumps Galapagos' arthritis drug and presses on with its own. Article

Pharma News

@FiercePharma: Investors trounce Aratana on dashed hopes for canine lymphoma drugs. FierceAnimalHealth article | Follow @FiercePharma

@EricPFierce: Sun Pharma unit Mutual Pharma recalls 216,766 bottles that may have chemical leaching labels. FiercePharmaManufacturing story | Follow @EricPFierce

@CarlyHFierce: Proud to say my home state is like, basically, the champion of pumpkin-growing. Where America's pumpkins come from. More | Follow @CarlyHFierce

> Novartis scores EU rec for blockbuster-to-be Entresto. News

> Alexion sues Canada over Soliris price cut attempt as drug cost debate explodes on center stage. Story

> Shire chalks up victory in Vyvanse patent battle. Report

Suggested Articles

Millions of tests are urgently needed as the virus keeps communities across the country in lockdown and hospitals are overwhelmed with patients.

The FDA granted its first emergency authorization for a rapid antibody blood test for COVID-19 developed by Cellex.

The ultimate goal is to move as many patients as possible out of the clinic that don’t need immediate, critical care.